| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/12/2004 | WO2003018776A3 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS |
| 02/12/2004 | WO2003014365A3 Plant glycogenin homologs and use thereof in starch modification |
| 02/12/2004 | WO2003014150A9 Fusion proteins for insect control |
| 02/12/2004 | WO2003012041A3 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/12/2004 | WO2003008585A3 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development |
| 02/12/2004 | WO2003008438A3 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 02/12/2004 | WO2003000897A8 Identification and characterization of phosphate transporter genes |
| 02/12/2004 | WO2002101016A3 A gene family encoding membrane steroid receptors |
| 02/12/2004 | WO2002097082A3 Engineered biosynthesis of novel polyenes |
| 02/12/2004 | WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules |
| 02/12/2004 | WO2002095010A3 Human secreted proteins |
| 02/12/2004 | WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 02/12/2004 | WO2002086089A3 The 76a11 polypeptide and uses thereof |
| 02/12/2004 | WO2002081623A3 Cell cycle nucleic acids, polypeptides and uses thereof |
| 02/12/2004 | WO2002081507A3 Interferon gamma polypeptide variants |
| 02/12/2004 | WO2002080848A3 Methods and materials for cancer treatment |
| 02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
| 02/12/2004 | WO2002076507A3 Uses of opg ligand to modulate immune responses |
| 02/12/2004 | WO2002072771A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 02/12/2004 | WO2002071927A3 Diagnosis and treatment of skeletal degeneration conditions |
| 02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
| 02/12/2004 | WO2002068649A3 Proteins and nucleic acids encoding same |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002064779A8 Peptide inhibitors of cellular proliferation |
| 02/12/2004 | WO2002064747A3 Fusion proteins based upon somatostatin receptors |
| 02/12/2004 | WO2002062953A3 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 02/12/2004 | WO2002062952A3 Non-cytotoxic pap mutants |
| 02/12/2004 | WO2002059299A3 Expression cloning method |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002055702A3 Human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | WO2002053580A3 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 02/12/2004 | WO2002052047A3 Methods for identifying g-protein coupled receptors associated with diseases |
| 02/12/2004 | WO2002052046A3 Oligonucleotide transfection screening method |
| 02/12/2004 | WO2002046411A3 Intestinal proteins |
| 02/12/2004 | WO2002045495A3 Transgenic mice containing targeted gene disruptions |
| 02/12/2004 | WO2002035981A3 Methods and compositions for the treatment of human immunodeficiency virus infection |
| 02/12/2004 | WO2002028352A3 A modulator of antiestrogen pharmacology |
| 02/12/2004 | US20040031074 Isolated from tobacco, recombinant nucleic acids containing the same, expression vectors and transgenic plants produced therewith |
| 02/12/2004 | US20040031072 Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| 02/12/2004 | US20040031067 Compositions and methods for preparing vascularized dermal reconstructs, vascularized skin grafts, and for enhancing vascularization in situ in response to a variety of medical conditions |
| 02/12/2004 | US20040030117 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 02/12/2004 | US20040030116 Used in identification of microorganisms which can be used to produce fine chemicals, the modulation of fine chemical production in C. glutamicum or related bacteria, the typing or identification of C. glutamicum as transformation markers |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030113 2,5-Dkg permeases |
| 02/12/2004 | US20040030110 Novel proteins and nucleic acids encoding same |
| 02/12/2004 | US20040030105 Improved methods for synthesis of phosphinothiol reagents and novel protected reagents for use in peptide ligation |
| 02/12/2004 | US20040030104 Rhamnose binding protein |
| 02/12/2004 | US20040030103 Anti-idiotype inducing antibodies, comprising at least one epitope from angiodenin, for the inhibition of angiogenesis |
| 02/12/2004 | US20040030100 For preventing, ameliorating, or correcting dysfunctions or diseases including obesity and diseases related to obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorders, schizophrenia, |
| 02/12/2004 | US20040030099 Regulation of human patched-like protein |
| 02/12/2004 | US20040030098 Polynucleotides encoding novel two splice variants of a human cell surface protein with immunologobulin folds, BGS5G and BGS5I |
| 02/12/2004 | US20040030097 Peptide mimetics of type I cytokine molecules such as interleukin 4, (IL-4), human growth hormone (HGH) and interleukin 2 (IL-2) |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029827 Remedies for heart failure |
| 02/12/2004 | US20040029826 Compounds for targeting hepatocytes in vivo |
| 02/12/2004 | US20040029809 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |
| 02/12/2004 | US20040029806 Chlamydia infections; antiarthritic agents; cardiovascular disorders |
| 02/12/2004 | US20040029804 Novel potassium channel |
| 02/12/2004 | US20040029802 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 02/12/2004 | US20040029795 Gene which modulate gene expression of protein |
| 02/12/2004 | US20040029793 Genetic engineering; antibodies; antiinflammatory agents, circulation diseases, anticancer agents, antidiabetic agents, gastrointestinal disorders |
| 02/12/2004 | US20040029791 Polypeptides; antitumor agents; suppression phosphorylation |
| 02/12/2004 | US20040029790 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029789 Qualitative, quantitative analysis; genetic engineering |
| 02/12/2004 | US20040029780 Deoxygenation uisng nitrogen; crosslinking hemoglobulin with glutaraldehyde ; artificial oxygen carrier |
| 02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
| 02/12/2004 | US20040029770 Genetic engineering; anticancer agents |
| 02/12/2004 | US20040029282 A promoter derived from an Arabidopsis ATP sulfurase gene, nucleic acid constructs, vectors, plant cells and transgenic plants comprising the promoter |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029280 Viral vectors with modified tropism |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029278 Recombinant alphaviruses which are capable of expressing a heterologous sequence in target cells |
| 02/12/2004 | US20040029252 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 02/12/2004 | US20040029251 Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture |
| 02/12/2004 | US20040029248 Chromodomain, Helicase, DNA-binding (CHD) |
| 02/12/2004 | US20040029234 Enhanced 2-keto-l-gulonic acid production |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029230 DNA strands useful for the production of parahydroxycinnamic acid and photoactive yellow protein in a suitable host expression system |
| 02/12/2004 | US20040029228 Cytokine receptor |
| 02/12/2004 | US20040029226 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029222 Proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029220 Novel proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029219 The proteins are antigenic and are useful as vaccine components to raise a protective immune response against Candida |
| 02/12/2004 | US20040029218 Used in preventing cancer, pharmaceuticals, diagnostics, biosensors and bioreactors |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 02/12/2004 | US20040029215 Industrially producing RFamide (RFRP ie Arg-Phe-Amide Related Peptides) peptides in a large scale comprises subjecting a fusion protein or peptide, in which an RFamide peptide is ligated to the N-terminal of a peptide |
| 02/12/2004 | US20040029210 Assay for paralytic shellfish toxin |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029196 Used in drug screening for anticancer/antitumor agents; tumor suppressor genes |
| 02/12/2004 | US20040029182 For diagnosis/therapy of colorectal cancer |
| 02/12/2004 | US20040029180 Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |